HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chylomicrons

A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS.
Networked: 314 relevant articles (22 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yamashita, Shizuya: 8 articles (01/2014 - 06/2007)
2. Maranhão, Raul C: 6 articles (03/2014 - 02/2003)
3. Maranhão, R C: 6 articles (03/2007 - 02/2000)
4. Vaziri, Nosratola D: 5 articles (04/2014 - 03/2005)
5. Masuda, Daisaku: 5 articles (01/2014 - 11/2009)
6. Tso, Patrick: 3 articles (04/2015 - 03/2011)
7. Watts, Gerald F: 3 articles (01/2015 - 02/2003)
8. Santos, Raul D: 3 articles (03/2014 - 02/2004)
9. Hanada, Hiroyuki: 3 articles (01/2014 - 11/2009)
10. Nishida, Makoto: 3 articles (01/2014 - 09/2011)

Related Diseases

1. Hypertriglyceridemia
2. Hyperlipidemias (Hyperlipidemia)
3. Chronic Kidney Failure (Chronic Renal Failure)
01/01/1994 - "Twelve cases of chylous ascites (defined by the presence of chylomicrons) among 230 patients with chronic renal failure treated in two peritoneal dialysis centers (Limoges and Saint-Pierre de la Réunion) are reported. "
04/01/2012 - "Chronic renal failure (CRF) is associated with hypertriglyceridemia and impaired clearance of very low density lipoprotein (VLDL) and chylomicrons which are largely due to lipoprotein lipase (LPL) deficiency/dysfunction. "
12/01/1996 - "Chronic renal failure (CRF) is associated with hypertriglyceridemia, impaired clearance of very low density lipoproteins (VLDL) and chylomicrons and their remnants as well as triglyceride-enrichment of various lipoproteins. "
03/01/2005 - "Chronic renal failure (CRF) is associated with premature atherosclerosis, impaired high-density lipoprotein (HDL)-mediated reverse cholesterol transport, depressed clearance, and elevated plasma concentrations of very low-density lipoprotein (VLDL), chylomicrons, and their atherogenic remnants. "
01/01/2011 - "Lipid abnormalities in end-stage renal disease are characterized by: (a) reduced serum apoA-1 and high-density lipoprotein (HDL) concentrations, impaired HDL maturation and defective HDL antioxidant, anti-inflammatory and reverse cholesterol transport properties; (b) impaired clearance of very low-density lipoprotein and chylomicrons by the muscle and adipose tissue and of their remnants by the liver leading to hypertriglyceridemia, accumulation of intermediate-density lipoprotein and chylomicron remnants, and (c) oxidative modification of LDL and lipoprotein remnants favored by their structural abnormalities, oxidative stress, and impaired HDL antioxidant activity. "
4. Obesity
5. Nephrotic Syndrome (Syndrome, Nephrotic)

Related Drugs and Biologics

1. Lipoproteins (Lipoprotein)
2. Chylomicron Remnants
3. Lipoprotein Lipase (Diacylglycerol Lipase)
4. Cholesterol
5. VLDL Lipoproteins
6. Lipase (Acid Lipase)
7. Triglycerides (Triacylglycerol)
8. Apolipoproteins B (ApoB)
9. LDL Receptors (LDL Receptor)
10. Apolipoprotein B-48

Related Therapies and Procedures

1. Fat-Restricted Diet (Diet, Fat Restricted)
2. Catheters
3. Peritoneal Dialysis
4. Enteral Nutrition (Feeding, Tube)
5. Blood Component Removal (Apheresis)